Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 23/02/19981 min de lecture
Ophthalmic Drug Products for Over-The-Counter Human Use; Proposed Amendment of Final Monograph
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is proposing to amend the final monograph for over-the-counter (OTC) ophthalmic drug products. The amendment adds a new warning and revises an existing warning for ophthalmic vasoconstrictor drug products. These products contain the ingredients ephedrine hydrochloride, naphazoline hydrochloride, phenylephrine hydrochloride, or tetrahydrozoline hydrochloride; and they are used to relieve redness of the eye due to minor eye irritations. This proposal is part of the ongoing review of OTC drug products conducted by FDA.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →